{
    "2021-02-07": [
        [
            {
                "time": "",
                "original_text": "生物医药行业周报：第四批集采正式开标 拟中标药品平均降幅52%符合预期",
                "features": {
                    "keywords": [
                        "集采",
                        "中标",
                        "药品",
                        "降幅",
                        "预期"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业2020业绩前瞻：2020板块分化明显 下半年医疗服务等有序复苏",
                "features": {
                    "keywords": [
                        "业绩",
                        "板块分化",
                        "医疗服务",
                        "复苏"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：新冠变异后是否需要常态化免疫加强？智飞新高后继续强烈看好",
                "features": {
                    "keywords": [
                        "新冠变异",
                        "免疫加强",
                        "智飞",
                        "新高"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物",
                        "疫苗"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "那些年机构抱团的牛股都怎么样了？",
                "features": {
                    "keywords": [
                        "机构抱团",
                        "牛股"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "医药生物“湘军”板块崛起 细胞龙头南华生物迎来战略发展期",
                "features": {
                    "keywords": [
                        "湘军",
                        "板块崛起",
                        "细胞龙头",
                        "南华生物",
                        "战略发展"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物",
                        "细胞技术"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "一年内入股锁定3年！创投PE圈炸锅",
                "features": {
                    "keywords": [
                        "入股锁定",
                        "创投PE",
                        "炸锅"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "汇添富全球消费混合、易方达蓝筹精选等这3只基金，值得投资",
                "features": {
                    "keywords": [
                        "基金",
                        "消费混合",
                        "蓝筹精选",
                        "投资"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "基金"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}